Table 3.

Clinical variables-wise categorization of the UCEC cohort analyzed via UALCAN

Sr. No	Clinical variable	Samples count per variable	Total samples count	Sample count having missing details	Final sample count subjected to analysis
1	Cancer stage
	Stage 1	n, 341		n, 0	n, 546
	Stage 2	n, 52
	Stage 3	n, 124
	Stage 4	n, 29
2	Age
	years = 21-40	n, 18	n, 546	n, 2	n, 544
	years = 41-60	n, 189
	years = 61-80	n, 292
	years = 81-100	n, 45
3	Geographical distribution
	Caucasian	n, 374		n, 45	n, 501
	African-American	n, 107
	Asian	n, 20
4	TP53 mutation status
	TP53-Mutatnt	n, 196		n, 4	n, 541
	TP53-NonMutant	n, 345

UCEC = Uterine corpus endometrial carcinoma, UALCAN = University of ALabama at Birmingham CANcer.